Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Interest Coverage Ratio (2020 - 2025)

Mirum Pharmaceuticals (MIRM) has 6 years of Interest Coverage Ratio data on record, last reported at 1.27 in Q4 2025.

  • For Q4 2025, Interest Coverage Ratio rose 81.24% year-over-year to 1.27; the TTM value through Dec 2025 reached 1.54, up 74.87%, while the annual FY2025 figure was 1.54, 74.87% up from the prior year.
  • Interest Coverage Ratio reached 1.27 in Q4 2025 per MIRM's latest filing, down from 0.72 in the prior quarter.
  • Across five years, Interest Coverage Ratio topped out at 0.72 in Q3 2025 and bottomed at 14.08 in Q1 2021.
  • Average Interest Coverage Ratio over 5 years is 6.71, with a median of 7.22 recorded in 2023.
  • Peak YoY movement for Interest Coverage Ratio: decreased 16.7% in 2023, then skyrocketed 120.41% in 2025.
  • A 5-year view of Interest Coverage Ratio shows it stood at 12.1 in 2021, then surged by 35.24% to 7.84 in 2022, then decreased by 16.7% to 9.15 in 2023, then grew by 26.0% to 6.77 in 2024, then soared by 81.24% to 1.27 in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Coverage Ratio were 1.27 in Q4 2025, 0.72 in Q3 2025, and 1.39 in Q2 2025.